5% STAKE4884.TTSECAYMAN ISLANDS

Evo Fund lowers stake in Kringle Pharma to 12.46%

Stake history

10%12%14%16%18%20%22%19.60%Aug 8Aug 8: 19.60% · S100WHGR18.91%Aug 22Aug 22: 18.91% · S100WKRA18.24%Sep 24Sep 24: 18.24% · S100WQ7A17.27%Oct 15Oct 15: 17.27% · S100WULJ17.23%Oct 16Oct 16: 17.23% · S100WVGD16.21%Dec 3Dec 3: 16.21% · S100X7ZO15.35%Mar 18Mar 18: 15.35% · S100XRCM12.46%Apr 8Apr 8: 12.46% · S100XXHS
10%12%14%16%18%20%22%19.60%Aug 8Aug 8: 19.60% · S100WHGR18.91%Aug 22Aug 22: 18.91% · S100WKRA18.24%Sep 24Sep 24: 18.24% · S100WQ7A17.27%Oct 15Oct 15: 17.27% · S100WULJ17.23%Oct 16Oct 16: 17.23% · S100WVGD16.21%Dec 3Dec 3: 16.21% · S100X7ZO15.35%Mar 18Mar 18: 15.35% · S100XRCM12.46%Apr 8Apr 8: 12.46% · S100XXHS

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2026-04-08 11:20 JST concerning Kringle Pharma, Inc. Reported holding ratio: 12.46%, previous report: 15.35%.

Open the price chart on TradingView.

Source: EDINET S100XXHS ↗ · PDL1.0 · Not investment advice